These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

923 related articles for article (PubMed ID: 20081869)

  • 1. Anti-virulence strategies to combat bacteria-mediated disease.
    Rasko DA; Sperandio V
    Nat Rev Drug Discov; 2010 Feb; 9(2):117-28. PubMed ID: 20081869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-virulence Strategies to Target Bacterial Infections.
    Mühlen S; Dersch P
    Curr Top Microbiol Immunol; 2016; 398():147-183. PubMed ID: 26942418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting virulence not viability in the search for future antibacterials.
    Heras B; Scanlon MJ; Martin JL
    Br J Clin Pharmacol; 2015 Feb; 79(2):208-15. PubMed ID: 24552512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antivirulence compounds: a future direction to overcome antibiotic resistance?
    Buroni S; Chiarelli LR
    Future Microbiol; 2020 Mar; 15():299-301. PubMed ID: 32286100
    [No Abstract]   [Full Text] [Related]  

  • 5. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
    Dickey SW; Cheung GYC; Otto M
    Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial signaling as an antimicrobial target.
    Ellermann M; Sperandio V
    Curr Opin Microbiol; 2020 Oct; 57():78-86. PubMed ID: 32916624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible drugs for the treatment of bacterial infections in the future: anti-virulence drugs.
    Ogawara H
    J Antibiot (Tokyo); 2021 Jan; 74(1):24-41. PubMed ID: 32647212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The art of antibacterial warfare: Deception through interference with quorum sensing-mediated communication.
    Rampioni G; Leoni L; Williams P
    Bioorg Chem; 2014 Aug; 55():60-8. PubMed ID: 24823895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biology and future prospects of antivirulence therapies.
    Cegelski L; Marshall GR; Eldridge GR; Hultgren SJ
    Nat Rev Microbiol; 2008 Jan; 6(1):17-27. PubMed ID: 18079741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance and virulence: Understanding the link and its consequences for prophylaxis and therapy.
    Guillard T; Pons S; Roux D; Pier GB; Skurnik D
    Bioessays; 2016 Jul; 38(7):682-93. PubMed ID: 27248008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel approaches to bacterial infection therapy by interfering with cell-to-cell signaling.
    Rasko DA; Sperandio V
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.3. PubMed ID: 19235150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parallels among natural and synthetically modified quorum-quenching strategies as convoy to future therapy.
    Gupta K; Daroch P; Harjai K; Chhibber S
    Microbiology (Reading); 2019 Dec; 165(12):1265-1281. PubMed ID: 31264956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel agents to inhibit microbial virulence and pathogenicity.
    Escaich S
    Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding and overcoming antibiotic resistance.
    Richardson LA
    PLoS Biol; 2017 Aug; 15(8):e2003775. PubMed ID: 28832581
    [No Abstract]   [Full Text] [Related]  

  • 15. Quorum Sensing Inhibition by Marine Bacteria.
    Borges A; Simões M
    Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31340463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial fitness shapes the population dynamics of antibiotic-resistant and -susceptible bacteria in a model of combined antibiotic and anti-virulence treatment.
    Ternent L; Dyson RJ; Krachler AM; Jabbari S
    J Theor Biol; 2015 May; 372():1-11. PubMed ID: 25701634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibition of bacterial two-component systems to combat antibiotic resistance and virulence.
    Worthington RJ; Blackledge MS; Melander C
    Future Med Chem; 2013 Jul; 5(11):1265-84. PubMed ID: 23859207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.
    Wang CH; Hsieh YH; Powers ZM; Kao CY
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
    Annunziato G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fallacies of hope: will we discover new antibiotics to combat pathogenic bacteria in time?
    Vicente M; Hodgson J; Massidda O; Tonjum T; Henriques-Normark B; Ron EZ
    FEMS Microbiol Rev; 2006 Nov; 30(6):841-52. PubMed ID: 17064283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.